3- ((((3- fluorophenyl)((3,4,5- trifluorophenyl)methyl)amino)carbonyl)oxy)- 1- (2- oxo- 2- (2- thienyl)ethyl)- 1- azoniabicyclo(2.2.2)octane

a bronchodilator; structure in first source

Also Known As:

CHF 5407; CHF-5407; CHF5407

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

1.	Droege, Christopher A: 1 article (02/2017)
2.	Ernst, Neil E: 1 article (02/2017)
3.	Mastrodicasa, Mark A: 1 article (02/2017)
4.	Mulhall, Aaron M: 1 article (02/2017)
5.	Panos, Ralph J: 1 article (02/2017)
6.	Zafar, Muhammad A: 1 article (02/2017)

1.	Chronic Obstructive Pulmonary Disease (COPD) 02/01/2017 - "Areas covered: This article reviews the clinical efficacy and adverse effects of currently available LAMAs in COPD treatment as well as developing LAMAs in early clinical trials and preclinical studies (V0162, TD-4208, CHF 5407, AZD9164, AZD8683, bencycloquidium). "

1.	AZD9164